2006
DOI: 10.2146/ajhp050544
|View full text |Cite
|
Sign up to set email alerts
|

Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
8
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 5 publications
2
8
0
Order By: Relevance
“…There was no reduction in the measured voriconazole concentration, consistent with what was reported in previous studies (i.e., voriconazole is stable in an acidic environment). 19 Seven days after exposure to heat at 60 °C, a significant peak with a retention time of 3.3 minutes was detected, and the resulting voriconazole concentration was reduced to about 55% of its initial value. Fifteen days after exposure to heat, the degradation peak increased in size, while the voriconazole further decreased to about 22% of the initial concentration.…”
Section: Resultsmentioning
confidence: 94%
See 3 more Smart Citations
“…There was no reduction in the measured voriconazole concentration, consistent with what was reported in previous studies (i.e., voriconazole is stable in an acidic environment). 19 Seven days after exposure to heat at 60 °C, a significant peak with a retention time of 3.3 minutes was detected, and the resulting voriconazole concentration was reduced to about 55% of its initial value. Fifteen days after exposure to heat, the degradation peak increased in size, while the voriconazole further decreased to about 22% of the initial concentration.…”
Section: Resultsmentioning
confidence: 94%
“…There was a negligible degradation peak at 2.4 minutes, with no significant reduction in the voriconazole concentration after exposure to hydrogen peroxide, consistent with previously reported data. 19 Photodiode array analyses of the spectra of all degradation samples ensured the purity of the voriconazole peak (retention time of 4.6 minutes). No peaks for impurities or byproducts overlapped with the voriconazole peak.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…7,8 As voriconazole is not commercially available in an ophthalmic preparation, solutions must be prepared using the IV formulation. 4,9,10 A 1% solution is most commonly used, prepared using the manufacturer instructions for IV administration. A study by Clode et al 4 demonstrated that the highest mean aqueous humor concentration and fewest side effects in horses were achieved by the use of a 1% voriconazole solution.…”
Section: Introductionmentioning
confidence: 99%